Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15397 total
Lifecore Biomedical reported Q1 fiscal 2026 results on May 6, posting sales of $23.2 million — well short of the $26.5 million consensus estimate — alongside a loss per share of $0.43 versus an expected $0.24 loss.…
MZTI arrives at this week's note bruised from a revenue miss, a fresh analyst target cut, and options positioning that has turned sharply defensive — while a completed acquisition adds a new strategic layer that the…
Lam Research enters the second week of May with one of the sharpest recoveries in the semiconductor equipment space — and the short book tells a big part of that story. The stock gained 10% on the week to close at…
Spire Inc. reported Q2 2026 results today with a clean beat on the bottom line — and an immediate cloud over the guidance outlook that options traders appear to have seen coming. Earnings per share came in at $3.76…
Kennametal Inc. enters the week having just reported quarterly earnings, with short sellers in full retreat and estimate momentum running near its highest level in years — two forces pulling in the same direction for…
Johnson & Johnson enters the second week of May having shed a month's worth of bearish positioning, even as the stock itself is down 7% from a month ago — a divergence that sits at the heart of this week's setup. The…
JetBlue Airways heads into its May 14 Q1 results with an unexpected ownership story dominating the tape — a fresh 13G filing revealing a new 10% shareholder just landed, even as short sellers sit near the stock's…
Jacobs Solutions delivered its clearest positive surprise in several quarters this week. Q2 adjusted EPS came in at $1.75, beating the $1.63 consensus estimate. Sales of $3.70 billion also topped expectations by a wide…
JPMorgan Chase heads into its May 19 investor event with a broad wave of insider selling at the top of the house — even as the stock holds near multi-month highs. The most striking feature of this week's data is the…
J&J Snack Foods Corp. enters the first week of May with an interesting internal contradiction: the stock is up 7% over the past month, but short sellers have been quietly rebuilding positions throughout that…
IFF reports Q1 2026 results today, walking into the print with options traders markedly less defensive than they were a month ago — a notable turn given that analysts have spent the past three weeks cutting…
IBM enters May with an unusual dynamic: short sellers are quietly stepping back just weeks after the stock suffered one of its worst single-session earnings drops in recent memory. Q1 results on April 22 sent the stock…
Intel heads into the week after its best monthly gain in years with the stock pricing in a recovery that Wall Street, on balance, hasn't yet endorsed. The setup is striking. The stock closed at $108.15 on May 5, up 28%…
Integra LifeSciences just delivered the kind of earnings beat that reminds shorts why crowded positions are dangerous — the stock jumped 24% in a single session, leaving 16% of its free float still short and the…
IDEX Corporation enters the week with a fresh catalyst: the company raised its quarterly dividend by 2.8% to $0.73 per share on May 6, an action that crystallises confidence in the earnings beat delivered just days…
IMG enters the post-earnings period in an unusual position: it just delivered one of its strongest quarterly results in years, yet the stock has lost ground on the week. Q1 2026 was a blowout. Revenue hit $1.031…
ITT heads into its May 21 earnings date with a split picture: short sellers have been gradually adding to positions over the past month while options traders have meaningfully dialled back the defensive hedging that…
JKHY delivered its Q3 2026 results this week into a market that had already been adding to short positions for six weeks straight — and the stock's 2% slide to $149.34 underlines the tension between a genuinely solid…
Hecla Mining walks into its Q1 2026 earnings call with the stock bruised, analysts trimming numbers, and options traders the most defensively positioned they've been all year. The price tells the story plainly. HL…
Monster Beverage walks into its Q1 results tomorrow with short sellers in full retreat, a well-timed analyst upgrade landing today, and a stock that — despite a soft week — has quietly recovered 5% from its April…
